Provention Bio, Inc. Gains 26.09%
Thu, Nov 03, 2022 at 07:27 PM
Provention Bio, Inc. (PRVB:NASDAQ) rocketted at $8.41, a gain of 26.1%. On Thu, Nov 03, 2022, PRVB:NASDAQ hit a New 2-Week High of $8.41. The stock got featured on our News Catalysts scanner on Thu, Nov 03, 2022 at 08:38 AM in the 'INVESTOR UPDATE' category. From Thu, Oct 20, 2022, the stock recorded 40.00% Up Days and 45.45% Green Days
About Provention Bio, Inc. (PRVB:NASDAQ)
Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in the sourcing, developing and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease. The company's pipeline includes PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-101.
Top 10 Gainers:
- Huadi International Group Co. Ltd. (HUDI:NASDAQ), 242.8%
- Renovare Environmental Inc. (RENO:NASDAQ), 77.78%
- Bull Horn Holdings Corp. (BHSE:NASDAQ), 44.67%
- Acutus Medical Inc. (AFIB:NASDAQ), 39.71%
- NerdWallet Inc. (NRDS:NASDAQ), 37.4%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 36.31%
- Aptose Biosciences Inc. (APTO:NASDAQ), 26.86%
- Provention Bio, Inc. (PRVB:NASDAQ), 26.09%
- Cardlytics, Inc. (CDLX:NASDAQ), 24.61%
- Greenhill & Co., Inc. (GHL:NYSE), 24.59%